F|T: The FinTech Times – The FTX clustercuss has ties to Canadian tech
Plus: FinTech investor Holt Xchange launches Web3 fund.
Newsletter
Get the pulse on Canadian tech, delivered.
The BetaKit Newsletter brings you the top stories, insights, and analysis on Canadian tech and startups each week. Subscribe now to ensure the best from BetaKit hits your inbox every week.
Canadian startup news of the week (11/13/22)
Plus: 1Password prepares to battle tech giants for passwordless future.
H|T: The Healthtech Times – OnCall & AeroDPC acquired, HealthJoy fundraises
Plus: Modernizing Medicine to pay $45M to resolve False Claims Act allegations.
R|T: The Retail Times – TouchBistro secures big funding amid looming recession
Plus: AirBnB records record revenue.
A|I: The AI Times – Inside Google’s commitment to QuĆ©bec tech
Plus: TuSimple fires its CEO amid federal probes.
S|W: The SaaS Weekly ā Elon had one hell of a first week at Twitter
Plus: 1Password acquires Texas-based Passage to fuel push into passkeys.
F|T: The FinTech Times – Layoffs hit Stripe and Chime
Plus: Mogo might get delisted from the Nasdaq.
Canadian startup news of the week (11/6/22)
Plus: Lightspeed and Nuvei increase revenues, see share prices drop.
H|T: The Healthtech Times – Inside Google’s quiet digital health acquisition
Plus: Cerebral lays off 20 percent of its staff.
R|T: The Retail Times – Solving Shopify: lost swagger? Or “enormous opportunity ahead?”
Plus: Lightspeed promotes CRO JD St-Martin to president as leadership overhaul continues.
A|I: The AI Times – U of T gets an AI nod from Eric Schmidt
Plus: CIFAR appoints 8 new AI chairs.
S|W: The SaaS Weekly ā A brutal week for Big Tech
Plus: Meet the new Chief Twit.
F|T: The FinTech Times – Wealthsimple stakes its crypto claim
Plus: WonderFi swaps CEO as company plans stock trading, sports betting hedge.
Canadian startup news of the week (10/30/22)
Plus: Placing future bets on Shopify and Wealthsimple.
H|T: The Healthtech Times – How VoxNeuro takes the subjectivity out of brain health assessments
Plus: Montrealās Inversago raises $95-million to revive failed class of weight-loss drugs.